Breast cancer is increasingly being studied as a
complex set of diseases with different biological and
clinical characteristics. A contribution to this diversity
might be provided by germline genetic variations.
Recent studies have investigated the differential effect of
genetic variants on the risk of developing particular
types of breast cancer, such as the ‘triple-negative’
subset or the hormone receptor-positive and the hormone
receptor-negative subsets